| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |